Upcoming IPOs
Shree Siddhivinayak Greentech Industries25 Nov – 27 Nov₹130.00 - ₹142.00NSE EmergeFoodlink F&B Holdings26 Nov – 30 NovTBAMainboardIntegris Medtech27 Nov – 1 DecTBAMainboardA J Packaging1 Dec – 3 DecTBANSE EmergeMonomark Engineering2 Dec – 4 DecTBAMainboardHindustan Coca ColaTBATBAMainboardShree Siddhivinayak Greentech Industries25 Nov – 27 Nov₹130.00 - ₹142.00NSE EmergeFoodlink F&B Holdings26 Nov – 30 NovTBAMainboardIntegris Medtech27 Nov – 1 DecTBAMainboardA J Packaging1 Dec – 3 DecTBANSE EmergeMonomark Engineering2 Dec – 4 DecTBAMainboardHindustan Coca ColaTBATBAMainboard
All IPOs

Sudeep Pharma IPO Review

MainboardListed

Pharmaceuticals · Listed on BSE , NSE · 21 Nov 2025 - 25 Nov 2025

R
Rajdeep
November 19, 2026
Issue Size
895.00 Cr
Price Band
₹563.00 - ₹593.00
Lot Size
25 Shares
Min Investment
₹14,825
GMP
₹115
Subscription
93.08x
₹58,313.72 Cr
IPO Timeline
IPO OpensDONE
21 Nov 2025
IPO ClosesDONE
25 Nov 2025
Basis of AllotmentDONE
26 Nov 2025
RefundsDONE
27 Nov 2025
Demat CreditDONE
27 Nov 2025
ListingDONE
28 Nov 2025

About Sudeep Pharma IPO

Sudeep Pharma IPO is to open on November 21, 2025. It is a Mainboard IPO that will raise ₹895 crores. The Sudeep Pharma IPO price band is fixed at ₹563 to ₹593 with a market lot of 25 Shares.

Advertisement

IPO Recommendations

Consensus review from market research firms & brokerage analysts

1
analyst
0
Apply
0
May Apply
1
Neutral
0
Avoid

Sudeep Pharma Review

ReviewerReviewDocument / Link
I
IPO Watch
NeutralView Review

User Reviews

Community Sentiment
Votes submitted by verified retail investors
0
votes
0
Apply
0
May Apply
0
Neutral
0
Avoid

Add Your Review

What is your recommendation for this IPO?

Loading options…

How would you rate this IPO (1 to 5)?

3
Disclaimer:

The IPO reviews, and recommendations published on this page are provided by respective authors, brokers, analysts, and contributors. These views do not represent the views of IPO Watch, its management, or its staff.

IPO Watch does not guarantee about the information or recommendations provided by third-party contributors. Use this content for informational and educational purposes only.

Investors are advised to do their own research, check offer documents, and consult a qualified financial adviser before making investment decisions.

IPO Watch reserves the right to review, modify, or remove any content that does not meet the editorial guidelines.

Advertisement

Frequently Asked Questions (FAQ)

Comments0

Join the discussion

Please sign in to leave a comment or reply.

Sorted by